We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$311M
AUM Growth
+$23.2M
Cap. Flow
+$4.78M
Cap. Flow %
1.54%
Top 10 Hldgs %
27.42%
Holding
106
New
2
Increased
40
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$891K
2
TMO icon
Thermo Fisher Scientific
TMO
+$779K
3
NEE icon
NextEra Energy
NEE
+$594K
4
DUK icon
Duke Energy
DUK
+$565K
5
XOM icon
ExxonMobil
XOM
+$535K

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Healthcare 13.42%
3 Industrials 12.11%
4 Consumer Staples 10.98%
5 Communication Services 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$126B
$2.38M 0.77%
45,680
+1,455
+3% +$72.7K
XLE icon
52
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$2.37M 0.76%
96,510
-13,980
-13% -$323K
AMZN icon
53
Amazon
AMZN
$3T
$2.27M 0.73%
14,700
+5,620
+62% +$891K
TMO icon
54
Thermo Fisher Scientific
TMO
$210B
$2.09M 0.67%
4,587
+1,632
+55% +$779K
HYG icon
55
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$2.02M 0.65%
23,127
-768
-3% -$66.8K
IBB icon
56
iShares Biotechnology ETF
IBB
$9.37B
$1.95M 0.63%
12,931
+235
+2% +$37.3K
HYD icon
57
VanEck High Yield Muni ETF
HYD
$4.44B
$1.93M 0.62%
30,980
-255
-0.8% -$15.8K
CTAS icon
58
Cintas
CTAS
$81.6B
$1.89M 0.61%
22,120
IAU icon
59
iShares Gold Trust
IAU
$63.5B
$1.78M 0.57%
54,839
COP icon
60
ConocoPhillips
COP
$144B
$1.77M 0.57%
33,405
-125
-0.4% -$6.16K
JNJ icon
61
Johnson & Johnson
JNJ
$612B
$1.57M 0.51%
9,573
GOOG icon
62
Alphabet (Google) Class C
GOOG
$4.6T
$1.48M 0.48%
14,280
VEU icon
63
Vanguard FTSE All-World ex-US ETF
VEU
$68B
$1.29M 0.41%
21,239
SYK icon
64
Stryker
SYK
$129B
$1.06M 0.34%
4,354
T icon
65
AT&T
T
$161B
$1.01M 0.33%
44,202
CVX icon
66
Chevron
CVX
$380B
$939K 0.3%
8,963
+15
+0.2% +$1.47K
PFE icon
67
Pfizer
PFE
$145B
$884K 0.28%
24,402
LLY icon
68
Eli Lilly
LLY
$996B
$835K 0.27%
4,473
CAT icon
69
Caterpillar
CAT
$407B
$821K 0.26%
3,542
-115
-3% -$23.8K
PAYX icon
70
Paychex
PAYX
$41.9B
$760K 0.24%
7,755
ORCL icon
71
Oracle
ORCL
$423B
$743K 0.24%
10,591
+27
+0.3% +$1.75K
IBM icon
72
IBM
IBM
$220B
$669K 0.22%
5,257
-89
-2% -$10.7K
SYY icon
73
Sysco
SYY
$39.8B
$644K 0.21%
8,190
AOR icon
74
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.71B
$583K 0.19%
10,888
-1,297
-11% -$69K
VEA icon
75
Vanguard FTSE Developed Markets ETF
VEA
$234B
$572K 0.18%
11,648
+1,013
+10% +$49.5K

Similar funds

Boston Research & Management's Q1 2021 Portfolio in Review

As of Q1 2021, Boston Research & Management held 106 positions worth $311M, up 8.1% from $287M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 2.8%. Boston Research & Management opened 2 new positions and exited 1, leaving the 106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Research & Management's largest Q1 2021 buy was Worthington Enterprises: 5,677 shares worth $234K.
  • Boston Research & Management added most to Amazon in Q1 2021, an estimated $891K increase.
  • Boston Research & Management's biggest Q1 2021 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $323K.
  • Boston Research & Management fully exited Mandiant, Inc. Common Stock in Q1 2021, selling an estimated $435K.
  • Boston Research & Management's ten largest holdings make up 27% of its $311M portfolio in Q1 2021.
  • Boston Research & Management opened 2 new positions and closed 1 in Q1 2021.
  • Boston Research & Management's portfolio value rose 8.1% quarter-over-quarter to $311M.

Based on Boston Research & Management's 13F filing for Q1 2021, filed 11 May 2021.